Galetskiĭ S A, Kopyl'tsov V N, Zhordaniia K I, Solov'ev Iu N, Revazova E S
Biull Eksp Biol Med. 1990 Aug;110(8):186-9.
Three new human cervical carcinoma xenografts was established from clinical tumor specimens of patients with I-II stages of disease. Growth characteristics of models are writing. Xenografts designated CC 9, 24 and 25 contain integrated DNA HPV, complemented DNA HPV-16. DNA CC 5 contain neither DNA HPV-16, nor DNA HPV-18.